INSIGHTS ON CELL & GENE OUTSOURCING ISSUES

• FACS Bulk Enrichment In Combination With Cell Cloning Systems Delivers Significant Savings For A CDMO

  Learn how the Cell Line Development (CLD) department at Celonic Ag was able to optimize their workflow with new technology geared towards shortening time lines and lightening workload. 

   

• 3 Issues With The Supply Chain In Cell And Gene Therapy

  Learn about some of the current issues impacting the manufacture and supply of cell and gene therapy products, including manufacturing and shipping costs, upscaling, and pandemic-related issues.

• Cell Therapy: Streamline The Path From Discovery To Commercialization

  Thermo Fisher Scientific provides the quality products, services, and support you need to advance your cell therapy from discovery to the clinic through to commercialization.

• Flexible Facility Design For Multi-Product Manufacturing Of Advanced Therapies

  Discover critical principles for the success of advanced therapy manufacturing facilities that benefit developers with established platform processes to sponsors and CDMOs involved in large-scale manufacturing.

• Cell Therapy Outsourcing: Current Thinking, Strategies And Trends

  Outsourced Pharma Chief Editor Louis Garguilo brings readers of Cell & Gene this collection of editorials on the current thinking, strategies, and trends in the cell-therapy space regarding outsourcing, and working with external partners. These editorials are based on interviews with CEOs sharing their analysis and best practices as they play out currently in their companies, and within our global industry. Garguilo covers Europe from the perspective of Miguel Forte, CEO, Bone Therapeutics, a most respected entrepreneur (MD, and professor) in the cell-therapy industry there. In the U.S., 30-year industry veteran and current CEO of Triumvira Immunologics, Paul Lammers, details an intriguing relationship his biopharma has with CDMOs, and shares his view on aspects of autologous and allogeneic therapies.

• Comparator Local Sourcing Strategies: Leveraging Advantages And Avoiding Common Pitfalls For Clinical Trials

  The growing demand for comparators is causing many supply chain managers to explore available sourcing options. Explore alternative local sourcing strategies, including advantages and disadvantages.

• Clinical Supply Optimization: Process Improvement Accelerates Clinical Trial Deliverables And Execution

  A biopharmaceutical sponsor required the study startup phase to be reduced to 91 days, involving comparator sourcing and blinding, kitting, packaging, labelling and distribution to the sites.

• Step Up To GMP Manufacturing Or Outsource To A CDMO

  Explore key factors to help you determine which strategy best suits your process, product, and team, as well as some general considerations and tips for succeeding in GMP manufacturing.

• One Size Does Not Fit All: Utilizing Multiple Technology Providers In Gene Therapy Manufacturing

  With a diverse landscape of potential partners, it is important to know what qualities to look for in a technology provider and how to traverse the challenges inherent in managing multiple relationships.

• Cell & Gene Therapy Supply Chain: Early Preparation Is Key

  Supply chain management for cell and gene therapies requires precise demand planning and forecasting